Impaired colour discrimination is associated with hallucinations in Dementia with Lewy Bodies
Objective: To explore the hypothesis that color discrimination impairment seen in Lewy body disorders is a specific biomarker of visual hallucinations rather than just overall…Differential temporal processing across Lewy body disorders and relation to cognitive fluctuations
Objective: To characterize differences in interval timing between patients with Parkinson’s disease and Dementia with Lewy bodies (DLB) and evaluate their relationship to cognitive fluctuations…Is Dizziness a sign before DLB onset?
Objective: I noticed that outpatients often continually complain about symptoms not found in PDD in DLB patients. In this time, I traced back the clinical…A comparison of serial position effects between patients with MCI due to Parkinson’s disease and patients with MCI due to Alzheimer’s disease
Objective: To compare the serial position effects (SPE) between patients with Mild Cognitive Impairment (MCI) due to Parkinson’s disease (PD-MCI) and patients with MCI due…Neuroprotective Effects of Combined Administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats
Objective: This study assessed the neuroprortective effects of combination of CoQ10 with vitamin E in Chronic Cerebral Hypoperfusion-induced neurodegeration (CCH-ND) model of rat. Background: Alzheimer’s…Pisa syndrome in Parkinson’s disease: a study on the neuropsychological profile.
Objective: To evaluate whether Pisa syndrome (PS) in Parkinson’s disease (PD) is associated with a specific profile of cognitive impairment. Background: PS is a complex…The interplay between cholinergic activity, attention, and turning in Parkinson’s disease
Objective: Explore how cholinergic activity (measured by short latency afferent inhibition [SAI]) and attention relate to quality of turning performance over a week of daily…Quantitative EEG measures reflect general cognitive status in Parkinson’s disease
Objective: To explore the utility of the quantitative electroencephalogram (EEG) as a potential biomarker of cognitive status in patients with Parkinson's disease (PD). Background: While…Plasma Soluble ST2 (sST2) levels are Higher in Neurodegeneration and Associate with PD Cognition
Objective: As plasma IL-33 levels are too low to accurately quantify, we measured plasma sST2 as a surrogate marker for IL-33 in samples from healthy…DBS for Parkinson-Dementia syndrome: Stimulation of both Globus Pallidus internus & the Nucleus Basalis of Meynert using the same electrode lead
Objective: The study proposed a new Deep Brain Stimulation (DBS) approach in Parkinson´s disease (PD): the Globus pallidus pars interna (GPi) + Nucleus Basalis of…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.